Abeers Marketing Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.22 M
as on 02-07-2024
- Revenue -100.00%
(FY 2022)
- Profit -184.83%
(FY 2022)
- Ebitda 88.51%
(FY 2022)
- Net Worth -1.22%
(FY 2022)
- Total Assets -21.54%
(FY 2022)
About Abeers Marketing
The Corporate was formerly known as Bioeze Pharmaceutical Company Private Limited. The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.22 M.
Mini Gupta, Charminder Kaur, and Shakti Singh serve as directors at the Company.
- CIN/LLPIN
U74991DL2006PTC148700
- Company No.
148700
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Abeers Marketing?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mini Gupta | Additional Director | 03-Apr-2024 | Current |
Charminder Kaur | Director | 09-May-2006 | Current |
Shakti Singh | Director | 21-Oct-2013 | Current |
Financial Performance and Corporate Structure Insights of Abeers Marketing.
Abeers Marketing Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 184.83% decrease in profit. The company's net worth dipped by a decrease of 1.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Abeers Marketing?
In 2018, Abeers Marketing had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Abeers Pharmaceuticals Private Limited
Active 12 years 5 monthsMini Gupta and Charminder Kaur are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 08 Mar 2016 | ₹1.22 M | Open |
How Many Employees Work at Abeers Marketing?
Unlock and access historical data on people associated with Abeers Marketing, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abeers Marketing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abeers Marketing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.